DOLUTEGRAVIR\LAMIVUDINE for Hepatitis c: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 5 adverse event reports in the FDA FAERS database where DOLUTEGRAVIR\LAMIVUDINE was used for Hepatitis c.

Most Reported Side Effects for DOLUTEGRAVIR\LAMIVUDINE

Side Effect	Reports	%	Deaths	Hosp.
Product dose omission issue	1,089	34.3%	1	16
Inappropriate schedule of product administration	256	8.1%	0	2
Product dose omission in error	234	7.4%	0	2
Product use issue	194	6.1%	3	4
Drug ineffective	137	4.3%	3	4
Pathogen resistance	137	4.3%	0	2
Intentional dose omission	112	3.5%	0	0
Viral load increased	104	3.3%	0	4
Rash	99	3.1%	2	14
Treatment noncompliance	97	3.1%	1	7
Viral mutation identified	94	3.0%	0	0
Adverse drug reaction	93	2.9%	0	0
Incorrect dose administered	92	2.9%	0	0
Off label use	92	2.9%	3	3
Fatigue	78	2.5%	3	6